Theralink Technologies, Inc.
THER · OTC
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 6.8% | 12.3% | 179% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 79.2% | 60.4% | 76.8% | 71% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,439.1% | -2,016% | -1,064.1% | -1,792.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -5,093.6% | -2,245% | -1,106.2% | -1,772.1% |
| EPS Diluted | -0.005 | -0.002 | -0.001 | -0.001 |
| % Growth | -127.3% | -120% | 23.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |